Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Study of NPC-12G Gel in Neurofibromatosis Type I
NCT04461886Phase 3Terminated
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Jul 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in neurofibromatosis type 1 (NF1), sponsored by Nobelpharma Co., Ltd.. Started Jul 2020; status: terminated.
02
Drugs
sirolimus
03
Conditions
neurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on NCT04461886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04461886.